10.3978/j.issn.1000-9604.2013.02.02
Determining the optimal time for bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplant in the treatment of multiple myeloma
multiple myeloma
25
R73;R5
2013-07-08(万方平台首次上网日期,不代表论文的发表时间)
共9页
166-174